Medications

Developing the first drug for a deadly bone disease

The U.S. Food and Drug Administration (FDA) recently approved palovarotene (Sohonos) as the first treatment for fibrodysplasia ossifcans progressiva (FOP), a severely disabling condition that causes abnormal bone formation ...

Genetics

Unraveling the network of brain tumor genetics

A new map of the network of genetic changes that drive the development of brain tumors has been revealed by UCL researchers. The genetic map, published in Brain, is comparable to a map of the London Underground—where different ...

page 7 from 40